Bionano Genomics Inc.

NASDAQ: BNGO · Real-Time Price · USD
3.01
-0.20 (-6.23%)
At close: Aug 15, 2025, 12:39 PM

Bionano Genomics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-112.02M -232.49M -132.6M -72.44M
Depreciation & Amortization
14.23M 13.91M 9.84M 3.37M
Stock-Based Compensation
9.74M 15.18M 22.42M 9.72M
Other Working Capital
4.27M -6.33M -3.96M 1.99M
Other Non-Cash Items
14.73M 92.99M 2.35M 848K
Deferred Income Tax
n/a n/a 1.76M -5.78M
Change in Working Capital
4.4M -14.77M -28.59M -7.65M
Operating Cash Flow
-68.92M -125.18M -124.82M -71.93M
Capital Expenditures
-103K -1.69M -3.3M -1.46M
Cash Acquisitions
n/a 96K -31.34M -49.09M
Purchase of Investments
-233.02M -111.26M -84.19M -313.39M
Sales Maturities Of Investments
306.96M 137.02M 200.89M 86.48M
Other Investing Acitivies
n/a n/a 720K -607K
Investing Cash Flow
73.84M 24.16M 82.77M -278.06M
Debt Repayment
-48.06M -47K -36K -15.01M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-10.06M 56.16M -85K 8.4M
Financial Cash Flow
-13.69M 113.81M 23.01M 336.11M
Net Cash Flow
-8.78M 12.86M -19.08M -13.88M
Free Cash Flow
-69.03M -126.87M -128.12M -73.39M